Filtering by: Harm Reduction

Jan
6
12:00 PM12:00

CDIAS PSMG: Alice Zhang

Not just for snacks – vending machines as a low-barrier harm reduction access method.

Alice Zhang, MD, MPH
Penn State College of Medicine

ABSTRACT:
Harm reduction-focused vending machines, delivering naloxone, fentanyl test strips, and other public health items, represent a potential non-stigmatizing, low-barrier approach to harm reduction that may increase access and engagement with underserved populations, reduce overdoses and related public health conditions, and health disparities in substance use disorder. Two interactive harm reduction-focused, community health-oriented vending machines have been implemented in central Pennsylvania, with two additional vending machines planned in 2026. This presentation will discuss barriers and facilitators to harm reduction vending machine implementation, as well as preliminary data on their acceptability, reach, utilization, and impact.

DOWNLOAD SLIDE SET
Back to PSMG Archive
View Event →
Apr
8
12:00 PM12:00

CDIAS PSMG: Andrea Jakubowski

Low Threshold Buprenorphine: What do we know and where do we go from here?

Andrea Jakubowski, MD, MS
Montefoire

ABSTRACT:
Over two decades into the opioid overdose crisis, buprenorphine remains underutilized and inaccessible to many people with opioid use disorder. Improving accessibility and utilization requires attention to where treatment is offered and how patients are treated once they enter care. In this presentation, Dr. Jakubowski will describe: 1) principles of low-threshold buprenorphine; 2) clinical and implementation data on syringes services program (SSP)-based buprenorphine programs; 3) early findings from Dr. Jakubowski’s NIDA K23 examining implementation of long-acting injectable buprenorphine in SSP and primary care clinics; 4) description and rationale of CTN-0155: Low-Threshold Buprenorphine Treatment at Syringe Services Programs: A Type I Hybrid Effectiveness-implementation Trial.

DOWNLOAD SLIDE SET
Back to PSMG Archive
View Event →